Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-
Administration, Oral
Animals
Area Under Curve
Arthritis, Rheumatoid
/ drug therapy
Calcium
/ metabolism
Calcium Channel Blockers
/ pharmacokinetics
Calcium Release Activated Calcium Channels
/ antagonists & inhibitors
Clinical Trials, Phase I as Topic
Drug Discovery
Humans
Jurkat Cells
Male
Mice
Mice, Inbred BALB C
Rats
Rats, Inbred Lew
Structure-Activity Relationship
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
09 12 2021
09 12 2021
Historique:
pubmed:
30
11
2021
medline:
22
1
2022
entrez:
29
11
2021
Statut:
ppublish
Résumé
The role of calcium release-activated calcium (CRAC) channels is well characterized and is of particular importance in T-cell function. CRAC channels are involved in the pathogenesis of several autoimmune diseases, making it an attractive therapeutic target for treating inflammatory diseases, like rheumatoid arthritis (RA). A systematic structure-activity relationship study with the goal of optimizing lipophilicity successfully yielded two lead compounds,
Identifiants
pubmed: 34843241
doi: 10.1021/acs.jmedchem.1c01403
doi:
Substances chimiques
Calcium Channel Blockers
0
Calcium Release Activated Calcium Channels
0
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM